Literature DB >> 2024484

Genetic and biochemical characterization of vaccinia virus genes D2L and D3R which encode virion structural proteins.

L M Dyster1, E G Niles.   

Abstract

Polyclonal antisera raised against fusion proteins containing portions of the vaccinia virus D2L and D3R proteins were prepared. Immunoprecipitation of pulse-labeled infected cell extracts and Western blot analysis demonstrated that genes D2L and D3R encode 16.9- and 27-kDa proteins, respectively. Both are synthesized late during infection and there is no evidence for proteolytic processing of either protein. Western blots of purified virus and subvirion fractions showed that D2L and D3R are virion components, residing in a detergent-insoluble fraction, containing viral core structural proteins. Trypsin sensitivity experiments suggest that each is found in an equivalent position within the virus core. Pulse-chase analysis showed that both proteins exhibit biphasic stability in which an unstable nascent component is replaced by a stable form. This observation suggests that the stable component results from the insertion of D2L and D3R into an immature core structure. The DNA sequence of four ts mutants previously mapped to genes D2L and D3R is reported. Analysis of the ability of each mutant to synthesize and process viral proteins showed that protein synthetic patterns were indistinguishable from wild type, however, three of the four mutants were defective in the processing of the major virion structural precursor, p4a. Unlike the biphasic stability observed in wild-type infected cells, D2L and D3R were totally degraded in cells infected at 40 degrees with any of the four ts mutants. Stability of the D2L and D3R proteins, in cells treated with rifampicin, is unaffected which demonstrates that a block in morphogenesis is not directly responsible for the observed instability of the mutant proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024484     DOI: 10.1016/0042-6822(91)90586-z

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Structure/Function analysis of the vaccinia virus F18 phosphoprotein, an abundant core component required for virion maturation and infectivity.

Authors:  Nadi T Wickramasekera; Paula Traktman
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

3.  Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

4.  Identification of a poxvirus gene encoding a uracil DNA glycosylase.

Authors:  C Upton; D T Stuart; G McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

5.  Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2.

Authors:  S Wang; S Shuman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  The E6 protein from vaccinia virus is required for the formation of immature virions.

Authors:  Olga Boyd; Peter C Turner; Richard W Moyer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  trans processing of vaccinia virus core proteins.

Authors:  P Lee; D E Hruby
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  A poxvirus-encoded uracil DNA glycosylase is essential for virus viability.

Authors:  D T Stuart; C Upton; M A Higman; E G Niles; G McFadden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  Adenosine N1-oxide inhibits vaccinia virus replication by blocking translation of viral early mRNAs.

Authors:  E M Kane; S Shuman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.